March 02, 2015 7:54 AM ET


Company Overview of MetronomX, Pte. Ltd.

Company Overview

MetronomX, Pte. Ltd. develops cancer chemotherapeutic metronomic therapies. It develops MNX-100 for relapsing and/or refractory neuroblastoma and medulloblastoma; and MNX-200, a metronomic formulation of an approved and used IV cancer chemotherapeutic drug. The company was founded in 2010 and is based in Houston, Texas.

5138 Cheena Drive

Houston, TX 77096

United States

Founded in 2010



Key Executives for MetronomX, Pte. Ltd.

Chief Executive Officer and Director
Age: 53
President and Director
Age: 58
Chief Medical Officer and Member of Scientific Advisory Board
Consulting Chief Scientific Officer
Consulting Scientific Officer and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Abbott Laboratories Residential Development Fund, Inc. United States
Blue Ash Therapeutics, LLC United States
Zuellig Botanicals, Inc. United States
Asahi Kasei Pharma America Corporation United States
Raritan Pharmaceuticals Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MetronomX, Pte. Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at